MedTrace Logo

Nicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer

NCT01084733 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 115

Last updated 2021-07-14

No results posted yet for this study

Summary

The objective of this study is to evaluate the relationship between serum nicotine levels and tumor response of squamous cell cancers of the head and neck (SCCHN) to radiotherapy alone or in combination with chemotherapy.

Correlation of RECIST response, volumatic response, pathologic response (in patients receiving post-treatment neck dissection), and hemodynamic response (tumor oxygenation and blood flow) will be performed.

Conditions

  • Larynx Cancer
  • Lip Cancer
  • Oral Cavity Cancer
  • Pharyngeal Cancer
  • Oropharyngeal Cancer

Sponsors & Collaborators

  • Mahesh Kudrimoti

    lead OTHER

Principal Investigators

  • Mahesh Kudrimoti, MD · University of Kentucky

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01084733 on ClinicalTrials.gov